B Group, Inc. 13F Holdings · Q2 2026
B Group, Inc. reported 18 securities worth $213.01M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: QQQ (17.29%), ADMA (12.82%), PALI (11.20%). Among its top 25 positions this quarter: 2 new, 5 added, 1 trimmed, 3 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | QQQ | INVESCO QQQ TR | $36.8M | 17.29% | 50,000 | New |
| 2 | ADMA | ADMA BIOLOGICS INC | $27.3M | 12.82% | 3.3M | Added |
| 3 | PALI | PALISADE BIO INC | $23.9M | 11.20% | 11.4M | Hold |
| 4 | NRXP | NRX PHARMACEUTICALS INC | $16.7M | 7.86% | 4.1M | Added |
| 5 | FTH | FAETH THERAPEUTICS INC | $15.3M | 7.16% | 610,169 | New |
| 6 | TSHA | TAYSHA GENE THERAPIES INC | $12.3M | 5.76% | 1.8M | Hold |
| 7 | PRAX | PRAXIS PRECISION MEDICINES I | $11.1M | 5.22% | 33,237 | Hold |
| 8 | CLLS | CELLECTIS S A | $9.8M | 4.62% | 3.3M | Hold |
| 9 | ZLAB | ZAI LAB LTD | $8.6M | 4.02% | 450,646 | Hold |
| 10 | GPCR | STRUCTURE THERAPEUTICS INC | $7.5M | 3.53% | 140,000 | Added |
| 11 | ORKA | ORUKA THERAPEUTICS INC | $7.1M | 3.35% | 75,000 | Hold |
| 12 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $6.2M | 2.93% | 1.5M | Hold |
| 13 | SYRE | SPYRE THERAPEUTICS INC | $6.2M | 2.92% | 70,000 | Trimmed |
| 14 | AURA | AURA BIOSCIENCES INC | $5.4M | 2.55% | 764,243 | Added |
| 15 | ASMB | ASSEMBLY BIOSCIENCES INC | $4.8M | 2.27% | 175,706 | Hold |
| 16 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $4.7M | 2.22% | 67,500 | Hold |
| 17 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.5M | 2.12% | 135,000 | Hold |
| 18 | SGHT | SIGHT SCIENCES INC | $3.7M | 1.72% | 970,000 | Hold |
| 19 | FHTX | FOGHORN THERAPEUTICS INC | $976,000 | 0.46% | 200,000 | Added |
| 20 | APGE | APOGEE THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 21 | REPL | REPLIMUNE GROUP INC | $0 | 0.00% | 0 | Exited |
| 22 | SLNO | SOLENO THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR